MarginsXMarginsX
Home › Markets › RAPH

Raphael Pharmaceutical Inc. (RAPH)

RAPH is quoted over the counter, not listed on an exchange. Raphael Pharmaceutical Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · October 16, 2026
$1.51
No trades since Oct 16, 2026; later closes repeat the last quote
1-year return
+51.0%
Market cap
$30.5M
Nano cap. From the Oct 16, 2026 last trade × 20.2M shares (10-Q cover page, Aug 14, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerRAPH, quoted over the counter
SEC CIK0001415397
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeMedicinal Chemicals & Botanical Products
Business addressLas Vegas, NV
Incorporated inNV

Warning signs

Cash runway
0.8 months
$1K cash at June 30, 2026
Share count, 1 year
+2.8%
2025-08-12 to 2026-08-14 · +23.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about our ability to continue as a going concern for a period within one year from the date of the financial statements included elsewhere in this Quarterly Report."
10-Q 2026-08-14
Cash and burn$1K cash; operating cash flow -$4K a quarter.Report 2026-06-30
Shares outstanding20,176,418 (2026-08-14); 19,626,418 a year earlier; 16,368,168 three years earlier.Cover page 2026-08-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorElkana Amitai CPA, Mitzpe Netofa, IsraelPCAOB Form AP 2026-03-31
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$223K$0$1KNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$229K-$44K$1KNo debt tagsNeeds four quarters10-Q 2026-08-14
Q4 2025
2025-12-31
Not filed-$273K$46K$45KNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$255K-$17K$3KNo debt tagsNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed-$322K-$30K$20KNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$429K-$209K$50KNo debt tagsNeeds four quarters10-Q 2026-08-14
Q4 2024
2024-12-31
Not filed-$395K-$62K$19K$269KNeeds four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$326K-$80K$40KNo debt tagsNeeds four quarters10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32024-11-21
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-09-01

Source: SEC EDGAR submissions feed, 179 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier